• Je něco špatně v tomto záznamu ?

The Streptococcus milleri group in chronic obstructive pulmonary disease

L. Navratilova, J. Bardon, R. Novotny, J. Zatloukal, P. Jakubec, V. Kolek, M. Zapalka, F. Kopriva, P. Prochazkova, V. Raclavsky

. 2016 ; 160 (3) : 378-384. [pub] 20160421

Jazyk angličtina Země Česko

Typ dokumentu kazuistiky, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17016668

Grantová podpora
NT13560 MZ0 CEP - Centrální evidence projektů

BACKGROUND AND AIMS: S. anginosus, constellatus and intermedius, also known as the Streptococcus milleri group (SMG) are three streptococcal species more frequently detected in cases of invasive disease, abscesses and empyema in particular. Recent research suggests they play a role in exacerbations of cystic fibrosis (CF). Owing to poor recovery on standard culture media and difficult differentiation from non-pathogenic streptococci, SMG may be underdiagnosed in routine settings. We aimed to establish the incidence of SMG in chronic obstructive pulmonary disease (COPD) patients compared to CF patients and to examine possible links of SMG to exacerbations that plays a key role in progression of COPD. METHODS: Altogether, 90 respiratory tract samples of patients suffering from CF or COPD were examined during the period from July 2012 to December 2013. Semi-selective McKay agar was used for primary cultivation of SMG and MALDI TOF MS was used for species identification that was confirmed by biochemical profiling and specific PCR. RESULTS: We confirmed the presence of SMG in CF (17.6% incidence in adult patients) and newly established its presence in COPD (10.3% incidence). In COPD, SMG was detected in 4 cases of acute exacerbations, where no other bacterial pathogen was detected. In 3/4 cases, increased CRP level indicated bacterial infection as a cause of the exacerbation and in all 3 cases, patients recovered during antibiotic treatment. CONCLUSIONS: Our data indicate SMG may act as opportunist pathogens able to cause exacerbations in COPD.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17016668
003      
CZ-PrNML
005      
20190701125127.0
007      
ta
008      
170516s2016 xr f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2016.017 $2 doi
035    __
$a (PubMed)27132809
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Navrátilová, Lucie $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic
245    14
$a The Streptococcus milleri group in chronic obstructive pulmonary disease / $c L. Navratilova, J. Bardon, R. Novotny, J. Zatloukal, P. Jakubec, V. Kolek, M. Zapalka, F. Kopriva, P. Prochazkova, V. Raclavsky
520    9_
$a BACKGROUND AND AIMS: S. anginosus, constellatus and intermedius, also known as the Streptococcus milleri group (SMG) are three streptococcal species more frequently detected in cases of invasive disease, abscesses and empyema in particular. Recent research suggests they play a role in exacerbations of cystic fibrosis (CF). Owing to poor recovery on standard culture media and difficult differentiation from non-pathogenic streptococci, SMG may be underdiagnosed in routine settings. We aimed to establish the incidence of SMG in chronic obstructive pulmonary disease (COPD) patients compared to CF patients and to examine possible links of SMG to exacerbations that plays a key role in progression of COPD. METHODS: Altogether, 90 respiratory tract samples of patients suffering from CF or COPD were examined during the period from July 2012 to December 2013. Semi-selective McKay agar was used for primary cultivation of SMG and MALDI TOF MS was used for species identification that was confirmed by biochemical profiling and specific PCR. RESULTS: We confirmed the presence of SMG in CF (17.6% incidence in adult patients) and newly established its presence in COPD (10.3% incidence). In COPD, SMG was detected in 4 cases of acute exacerbations, where no other bacterial pathogen was detected. In 3/4 cases, increased CRP level indicated bacterial infection as a cause of the exacerbation and in all 3 cases, patients recovered during antibiotic treatment. CONCLUSIONS: Our data indicate SMG may act as opportunist pathogens able to cause exacerbations in COPD.
650    _2
$a akutní nemoc $7 D000208
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a cystická fibróza $x mikrobiologie $7 D003550
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a oportunní infekce $x mikrobiologie $7 D009894
650    _2
$a chronická obstrukční plicní nemoc $7 D029424
650    _2
$a infekce dýchací soustavy $x mikrobiologie $7 D012141
650    _2
$a sputum $x mikrobiologie $7 D013183
650    _2
$a streptokokové infekce $x mikrobiologie $7 D013290
650    _2
$a skupina Streptococcus milleri $x izolace a purifikace $7 D034364
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
700    1_
$a Bardoň, Jan, $u State Veterinary Institute in Olomouc, Jakoubka ze Stribra 1, Olomouc, Czech Republic $d 1964- $7 xx0082160
700    1_
$a Novotný, Radko $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic $7 xx0061155
700    1_
$a Zatloukal, Jaromír $u Department of Respiratory Medicine, University Hospital Olomouc, Czech Republic $7 xx0113000
700    1_
$a Jakubec, Petr, $u Department of Respiratory Medicine, University Hospital Olomouc, Czech Republic $d 1971- $7 mzk2007381840
700    1_
$a Kolek, Vítězslav, $u Department of Respiratory Medicine, University Hospital Olomouc, Czech Republic $d 1953-2020 $7 jn20000401390
700    1_
$a Zápalka, Martin $u Department of Pediatrics, University Hospital Olomouc, Czech Republic $7 xx0096385
700    1_
$a Kopřiva, František, $u Department of Pediatrics, University Hospital Olomouc, Czech Republic $d 1956- $7 xx0012473
700    1_
$a Procházková, Petra, $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic $d 1975- $7 xx0128423
700    1_
$a Raclavský, Vladislav $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic $7 xx0046827
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic $x 1213-8118 $g Roč. 160, č. 3 (2016), s. 378-384
856    41
$u http://biomed.papers.upol.cz/ $y domovská stránka časopisu
910    __
$a ABA008 $b A 1502 $c 958 $y 4 $z 0
990    __
$a 20170516 $b ABA008
991    __
$a 20190701125314 $b ABA008
999    __
$a ok $b bmc $g 1205814 $s 977477
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 160 $c 3 $d 378-384 $e 20160421 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
GRA    __
$a NT13560 $p MZ0
LZP    __
$b NLK118 $a Pubmed-20170516

Najít záznam

Citační ukazatele

Možnosti archivace